Group One Trading, L.P. Marker Therapeutics, Inc. Transaction History

Group One Trading, L.P.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	SELL	$0.24 - $4.58 $568 - $10,850	-2,369 Reduced 45.06%	2,889 $0
Q3 2022 Nov 09, 2022	BUY	$0.3 - $3.73 $630 - $7,833	2,100 Added 66.5%	5,258 $2,000
Q2 2022 Aug 11, 2022	SELL	$0.26 - $0.46 $7,089 - $12,542	-27,267 Reduced 89.62%	3,158 $1,000
Q1 2022 May 12, 2022	BUY	$0.37 - $1.0 $581 - $1,571	1,571 Added 5.44%	30,425 $13,000
Q4 2021 Feb 11, 2022	BUY	$0.95 - $1.72 $27,411 - $49,628	28,854 New	28,854 $27,000
Q2 2020 Aug 13, 2020	SELL	$1.69 - $2.79 $1,279 - $2,112	-757 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$1.59 - $3.35 $8,039 - $16,937	-5,056 Reduced 86.98%	757 $1,000
Q4 2019 Feb 10, 2020	SELL	$2.68 - $4.85 $21,172 - $38,315	-7,900 Reduced 57.61%	5,813 $17,000
Q3 2019 Nov 12, 2019	BUY	$4.1 - $9.0 $25,350 - $55,647	6,183 Added 82.11%	13,713 $70,000
Q2 2019 Aug 09, 2019	BUY	$5.15 - $7.92 $38,779 - $59,637	7,530 New	7,530 $60,000

475K

Ticker MRKR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,599,200
Market Cap $163M
Description
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufact...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.